Renske C. F. Hebing
Renske C. F. Hebing publishes mostly in Rheumatology, Immunology and Family Practice, on topics such as Rheumatoid Arthritis Research and Therapies, Biosimilars and Bioanalytical Methods and Medication Adherence and Compliance.
- World rank
- #2,880,062 of 7,710,434 ranked researchers
- Rank in Netherlands
- #59,347 of 107,149
- Works
- 33
- Citations
- 358
- Citations per work
- 10.8
What does Renske C. F. Hebing research?
Renske C. F. Hebing's work is mostly in Medicine (49%), Immunology and Microbiology (14%), Pharmacology, Toxicology and Pharmaceutics (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1648.9%
- Medicine1648.9%
- Everything else1030.3%
- Life Sciences720.8%
- 1Rheumatology27% of their works
- 2Immunology14% of their works
- 3Family Practice8% of their works
- 4Public Health, Environmental and Occupational Health8% of their works
- 5Toxicology7% of their works
- 6Genetics5% of their works
Research topics
- Rheumatoid Arthritis Research and Therapies
- Biosimilars and Bioanalytical Methods
- Medication Adherence and Compliance
- Pharmacovigilance and Adverse Drug Reactions
- Acute Lymphoblastic Leukemia research
- Chronic Lymphocytic Leukemia Research
- Statistical Methods in Clinical Trials
- Patient-Provider Communication in Healthcare
Which keywords describe Renske C. F. Hebing's research?
The keywords of their largest research topics: Inflammation, Rheumatoid Arthritis, Prognostic Factors, Biosimilars, Immunogenicity, Medication Adherence, Treatment Adherence and Acute Lymphoblastic Leukemia.
- Patient-Centered Care
- Adaptive Designs
- Chronic Lymphocytic Leukemia
- Childhood Cancer
- Acute Lymphoblastic Leukemia
- Medication Adherence
- Biosimilars
- Rheumatoid Arthritis
- Inflammation
- Prognostic Factors
- Immunogenicity
- Treatment Adherence
- Adverse Drug Reactions
- Pharmacovigilance
- Genomic Aberrations
- False Discovery Rate
- Physician Communication
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Inflammation221 topic
- Rheumatoid Arthritis221 topic
- Prognostic Factors122 topics
- Biosimilars101 topic
- Immunogenicity101 topic
- Medication Adherence81 topic
- Treatment Adherence81 topic
- Acute Lymphoblastic Leukemia71 topic
- Adverse Drug Reactions71 topic
- Childhood Cancer71 topic
- Pharmacovigilance71 topic
- Chronic Lymphocytic Leukemia51 topic
- Genomic Aberrations51 topic
- Adaptive Designs31 topic
- False Discovery Rate31 topic
- Patient-Centered Care31 topic
- Physician Communication31 topic
Where does Renske C. F. Hebing work?
Renske C. F. Hebing's main affiliation in the publication record is Reade, Netherlands.
How many publications and citations does Renske C. F. Hebing have?
OpenAlex counts 33 works and 358 citations for Renske C. F. Hebing, an h-index of 12, ranking #2,880,062 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Renske C. F. Hebing. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.